Summary:
Click image to enlarge
The PAUSE study is a clinical research study testing whether taking ustekinumab (STELARA ®) followed by an investigational drug (abatacept) can help control psoriasis.
If you are between 18-65 years old and have been diagnosed with psoriasis for six months or longer, you may be eligible to participate in the PAUSE study.
Qualified Participants May Receive:
All study-related care and drug are provided at no cost. Participants may be reimbursed for travel expenses and may receive compensation for some study visits during the course of the trial.